ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1364 National Cancer Institute Html en Sleep Disorders (PDQ®)–Health Professional Version Expert-reviewed information summary about causes and management of sleep disorders in people with cancer.
slow wave sleep0.645037
sleep difficulty0.586858
circadian sleep disorder0.585999
sleep disturbance0.734742
general sleep0.627531
self-reported sleep0.586211
sleep disturbances0.78937
sleep environment0.599417
general sleep hygiene0.610843
sleep history0.590036
poor sleep hygiene0.618457
sleep patterns0.707388
individual sleep patterns0.650508
sleep cycle.0.613137
sleep diary0.632064
subjective sleep quality0.612249
sleep disruption0.616368
severe sleep0.619271
sleep medicine report0.579291
Pittsburgh Sleep Quality0.612644
8-hour sleep period.0.649042
General Sleep Disturbance0.626985
different sleep trajectories0.61732
secondary sleep disorders0.654958
behavioral therapy0.643973
cancer experience sleep0.697426
numerous sleep parameters0.602184
sleep education0.598942
REM sleep0.663854
sleep0.906331
diary-measured sleep variables0.59623
sleep cycle0.621195
sleep outcomes0.569139
sleep medicine0.672639
common sleep disturbance0.63638
total sleep time0.611253
sleep quality0.73817
sleep disorders0.662401
progressively deepening sleep0.64769
Adequate sleep0.615183
sleep restriction0.71475
severe sleep disturbances0.604554
breast cancer0.670406
insomnia0.65868
randomized controlled trial0.60112
severe sleep disorder0.613455
sleep hygiene0.685071
NREM sleep0.616861
CLICK HERE
1651 National Cancer Institute Html en Milk Thistle (PDQ®)–Patient Version Expert-reviewed information summary about the use of milk thistle as a treatment for people with cancer.
cancer treatment0.701214
advanced liver cancer0.66555
PDQ cancer information0.729457
Cancer Complementary0.666923
clinical trials0.798052
U.S. Food0.649163
cancer information summary0.699946
alternative cancer therapies0.663524
clinical trial0.731299
CAM cancer research0.657056
patients0.673877
cancer patients0.654835
randomized clinical trial0.683387
Marian thistle0.690666
NCI PDQ cancer0.677418
cancer information database0.662437
radiation therapy0.660512
Therapies Editorial Board0.664492
cancer information0.734643
treatment0.70795
cancer prevention0.650452
Complementary Therapies Editorial0.677699
United States0.665688
Drug Administration0.682045
Cancer Information Specialist0.658528
cancer cells0.669779
milk thistle supplements0.741182
cancer cell lines0.655527
anticancer medications0.651405
Cancer Information Service0.697895
CAM therapies0.649867
treatment clinical trials0.654645
National Cancer Institute0.770559
alternative medicine0.692591
conventional treatment0.650077
St. Mary thistle0.707197
Federal Trade Commission0.651646
silymarin0.670265
Cancer Care page0.650369
breast cancer0.668147
PDQ summary0.650118
cancer clinical trials0.667946
alternative therapies0.674881
acute lymphoblastic leukemia0.665296
neck cancer0.65549
cancer information summaries0.662842
colorectal cancer cells0.652543
cancer0.828322
CLICK HERE
1907 National Cancer Institute Html es Tratamiento de la leucemia linfoblástica aguda en adultos (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfoblástica aguda en adultos.
siguientes procedimientos0.512309
células madre0.745172
posibles factores0.503357
leucemia linfocítica aguda0.520357
sudores nocturnos0.503905
leucemia linfoblástica aguda0.974441
células madre formadoras0.514124
hueso compacto0.512997
neoplasias mieloides0.503724
vía oral0.502952
rayos x0.503057
tirosina cinasa mesilato0.506883
enlace drugs approved0.528959
largo plazo0.502247
cromosoma filadelfia0.520834
célula madre mieloide0.525688
células t0.514618
efectos tardíos0.513015
células anormales.ampliar aspiración0.521673
líquido cefalorraquídeo0.529356
punción espinal.Ampliar0.503734
National Cancer Institute0.502969
siguientes riesgos0.502423
Instituto Nacional0.509996
célula madre linfoide0.511194
PDQ Tratamiento0.507876
general empeora0.503285
presente sección0.502319
leucemia mielógena0.512372
sistema nervioso central0.612
Physician Data Query0.510454
linfocitos t0.513897
leucemia mieloide aguda0.535285
siguientes enlaces0.502726
célula madre0.560418
células sanguíneas maduras0.551656
células formadoras0.516721
Filadelfia".Ampliar Cromosoma Filadelfia0.507706
terapia posremisión0.505736
cuidado paliativo0.502192
siguientes pruebas0.518516
CLICK HERE
1987 National Cancer Institute Html es Tratamiento de los tumores embrionarios del sistema nervioso central infantil (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del meduloblastoma infantil, los tumores embrionarios distintos del meduloblastoma y los tumores pineales infantiles.
sumario versa0.501558
siguientes procedimientos0.502311
células madre0.524991
efectos secundarios meses0.503043
siguientes aspectos0.500523
años edad0.500492
tratamiento mejora0.501438
dosis pequeñas administras0.501281
PDQ Descripción0.501938
sección información0.50094
efectos tardíos0.505196
carcinoma nevoide0.50085
PDQ Tumores0.506016
PDQ Efectos tardíos0.501814
líquido cefalorraquídeo0.521206
punción espinal.Ampliar0.500903
National Cancer Institute0.5005
tumores benignos0.508351
siguientes riesgos0.500413
médula ósea.ampliar aspiración0.502403
Instituto Nacional0.501732
PDQ Tratamiento0.505028
presente sumario0.501062
determinados cambios0.501002
riesgo promedio0.513411
nuevos tipos0.500625
riesgo alto.Riesgo promedio0.501723
sistema nervioso central0.814928
Physician Data Query0.50178
brain tumor0.501055
prueba irm0.500762
Aboutâ„¢ Brain Tumors0.500627
siguientes enfermedades0.501038
cuánto tumor0.503396
tumores embrionarios0.994005
imágenes seguirán0.500378
Cuánto tiempo0.500383
siguientes enlaces0.500476
SNC infantil recidivantes0.502864
Brain Tumor Consortium0.501941
infantil recidivantes0.502523
siguientes pruebas0.501153
CLICK HERE
2009 National Cancer Institute Html es Trasplante de células hematopoyéticas en la niñez (PDQ®)–Versión para profesionales de salud Información revisada por expertos acerca del uso del trasplante de células madre hematopoyéticas para el tratamiento del cáncer infantil.
mujeres donantes0.306393
múltiples incompatibilidades0.305809
HLA A0.36555
incompatibilidades ich-o0.306724
células progenitoras0.322599
Sin embargo0.310448
mejores abordajes0.305856
cordón umbilical mo0.310246
bone marrow relapse0.305504
células t0.3408
Marrow Transplant0.341721
Moderado Bajo0.314512
donantes momentos0.307307
stem cell transplantation0.321131
clase ii0.317893
donante fraterno0.317133
madre hematopoyéticas cmsp0.31029
Children's Oncology Group0.30909
intensive chemotherapy0.305653
TCH satisfactorios0.311984
siguientes antígenos0.307763
donantes mujeres0.306338
Transplant Clinical Trials0.309697
HLA DRB10.341366
eich aguda0.310608
DRB1 HLA DQB10.319182
dirección r-o0.30821
HLA DPB10.318384
células madre0.997289
donantes varones0.306485
células cd34+0.310327
leucemia linfoblástica aguda0.30978
marrow transplantation versus0.305832
bone marrow transplantation0.335932
Clinical Trials Network0.307815
stem cell0.328901
Oncology Group study0.308699
células cd340.331629
antígeno hla0.332107
Blood Marrow Transplant0.306328
células madre hla0.331292
eich aguda moderado0.306115
PDQ Tratamiento0.308981
bone marrow0.352242
células progenitoras cd340.312061
Marrow Transplant Research0.305769
células madre resultante0.314653
incompatibilidades r-o0.306646
EICH crónica0.314484
CLICK HERE
4388 National Cancer Institute Html en Risk Factors for Cancer Information about behaviors, exposures, and other factors that may influence the risk of cancer.
possible inherited cancer0.579042
sign0.325482
section0.325244
protective factors0.646351
avoidable risk factors0.633812
media0.323442
type0.323483
certain behaviors0.496195
wrong ideas0.432065
research0.328222
result0.323043
true risk factor0.577461
things0.325771
Common Cancer Myths0.549129
Hereditary Cancer Syndromes0.581459
Misconceptions page0.432753
relationship0.322662
increased risk0.439428
chemicals0.326011
potential risk factor0.567711
risk factors0.923045
certain substances0.487633
genetic mutations0.443709
chance0.323016
protective risk factors0.672248
certain cancers0.611938
lower risk0.460281
epidemiology studies0.437177
large groups0.438561
finding0.323802
people0.373455
certain risk factors0.746622
exposure0.356743
chances0.333077
scientists0.343939
family history0.579318
certain ways0.482584
person0.360237
Cancer risk factors0.679541
n’t0.355491
cancer0.820183
information0.349749
similar association0.428532
possible mechanism0.423041
CLICK HERE
16643 National Cancer Institute Html es Régimen Gonzalez (PDQ®)–Versión para pacientes Resumen de información revisada por expertos sobre el uso del régimen Gonzalez como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.
Centro Nacional0.304069
New Hampshire Avenue0.301293
Drug Administration0.300803
estadio ii0.30117
NCI Best Case0.302468
datos bibliográficos pubmed0.301383
siguientes preguntas0.300833
supervivencia promedio0.301242
James Beard0.301166
PDQ Régimen Gonzalez0.309993
National Cancer Institute0.301582
estudio clínico0.301423
siguientes riesgos0.301039
Instituto Nacional0.310951
Salud Complementaria0.305346
Visuals Online0.30094
complementarias revisa0.301324
siguientes efectos0.301323
Physician Data Query0.305467
enzimas pancreáticas0.367516
Estados Unidos0.312379
régimen gonzalez0.988904
libre uso0.300947
página manejo0.300877
Medicina Alternativa0.30166
¿El tratamiento0.301547
¿Los beneficios0.30081
juntos cam0.300775
siguientes formas0.301287
William Kelley0.301175
Clinical Oncology0.301179
Nicholas Gonzalez0.323344
Max Gerson0.301216
enzimas.Los resultados0.300995
Series Program0.300797
medicina complementaria0.336883
CLICK HERE
16833 National Cancer Institute Html en News and Events The latest news from the Office of Cancer Nanotechnology Research and the Alliance, as well as upcoming and past events attended by the Office of Cancer Nanotechnology Research staff, and relevant upcoming scientific meetings.
National Cancer Institute0.924974
CLICK HERE
16849 National Cancer Institute Html en Earlier Detection and Diagnosis Winning the battle in cancer is by way of its earlier detection. Find out here how nanotechnology for cancer can enable the next generation of diagnostics.
molecular contrast agents0.744126
magnetic resonance0.73913
gold nanoparticles0.758974
contrast agents0.928653
specific tumor type0.759045
nanoparticles0.799664
Kettering Cancer Center0.72147
single cancer cell0.739114
prostate cancer cells0.750158
local tumor response0.753856
self-assemblying nanoparticles0.709894
image contrast agents0.719631
current nanoscale imaging0.726633
tumor specific tissue0.778585
tumor types0.710578
magnetic resonance imaging0.73549
tissue biopsies0.710788
single cell level0.706857
tumor tissue0.754041
cancer cells0.798935
magnetic nanoparticles0.748727
Current imaging methods0.720015
surgical resection0.752605
molecular imaging agents0.749026
imaging contrast agents0.752812
Bioactivatable nanoparticles0.713538
tumor pre-seeding0.710938
novel imaging modalities0.716395
tumor growth0.708481
clinical cancer imaging0.759447
tumor cells0.829828
optical imaging contrast0.737025
lung cancer patients0.707897
Stanford University0.729305
modern imaging modalities0.717085
biological signatures0.716262
cancer detection0.708688
clinical cancer treatment0.738765
brain tumor0.708929
single circulating tumor0.753922
cancer cell death0.775613
Raman spectroscopic imaging0.712792
imaging modalities0.740521
MRI-PAT-Raman nanoparticles0.710131
silica-hybrid nanoparticles0.709652
prostate cancer0.754477
tumor DNA0.744446
cancer patient treatment0.749464
cell-free tumor DNA0.731784
CLICK HERE
17276 National Cancer Institute Html es Su propio cuidado Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas. Es importante que también se cuide a usted mismo y que pida ayuda.
Lotsa Helping Hands0.77931
busque ayuda0.925738
tanta emoción0.963692
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.